HURA — TuHURA Biosciences, Inc./NV
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-07-12.
Performance
Technicals
Others in Healthcare
Measured signals that fired on HURA
| date | signal | measured base rate |
|---|---|---|
| 2026-05-15 | Institutional holders jumped in a quarter ownership | -0.52% over 21 days · t = -0.38 · n = 1,553 not distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-05-28 | Bianco James A. Chief Executive Officer | Gift | 150.0K | 0.00 | 0 |
| 2024-10-18 | Bianco James A. Chief Executive Officer | Grant or award | 2.3M | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 4.4M | 2.5M |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.7M | 2.1M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8M | 986.9K |
| AQR CAPITAL MANAGEMENT LLC | 1.1M | 607.2K |
| STATE STREET CORP | 918.1K | 512.9K |
| NORTHERN TRUST CORP | 533.8K | 298.2K |
| VANGUARD FIDUCIARY TRUST CO | 514.0K | 287.1K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 454.0K | 253.6K |
| Bank of New York Mellon Corp | 378.7K | 211.6K |
| Apollon Wealth Management, LLC | 282.8K | 158.0K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-14 | 2026-08-14 | on EDGAR ↗ |
| 8-K | 2026-08-13 | 2026-08-07 | on EDGAR ↗ |
| 8-K | 2026-07-29 | 2026-07-28 | on EDGAR ↗ |
| ARS | 2026-07-09 | 2025-12-31 | on EDGAR ↗ |
| DEFA14A | 2026-07-09 | — | on EDGAR ↗ |
| DEF 14A | 2026-07-09 | 2026-08-18 | on EDGAR ↗ |
| 8-K | 2026-07-07 | 2026-06-30 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Tuhura Biosciences, Inc./NV (HURA) filed form 8-K · 2026-08-21 · SEC EDGAR
- Tuhura Biosciences, Inc./NV (HURA) filed form 8-K · 2026-08-19 · SEC EDGAR
- Tuhura Biosciences, Inc./NV (HURA) filed form 8-K · 2026-08-14 · SEC EDGAR
- TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update · 2026-08-14
- TuHURA Biosciences, Inc./NV (HURA) filed form 10-Q · 2026-08-14 · SEC EDGAR
- TuHURA Biosciences, Inc./NV (HURA) filed form 8-K · 2026-08-14 · SEC EDGAR
Ask the AI about HURA
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →